Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb study of intravenous rhEPO-Fc maintenance treatment in Chinese hemodialysis patients with anemia due to chronic kidney disease
CTR20263468Phase 3Active
- Sponsor
- Meiye Biotech
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in Uraemic Anaemia, sponsored by Meiye Biotech. Started Sep 2026; status: active.
02
Drugs
epoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on CTR20263468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263468.